Alto Neuroscience

Price & Volume

Stats

52W Range	$1.60-$15.04
Market Cap	$97.4M
Shares Short	1M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$2.39

News

Yahoo Finance • yesterday

Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Brainstorm Cell Therapeutics Inc. (OTC: BCLI); Flywire Corporation (NASDAQ: FLYW); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf

Yahoo Finance • 4 days ago

Investors who lost money on Alto Neuroscience, Inc.(ANRO) should contact Levi & Korsinsky about pending Class Action - ANRO

Yahoo Finance • 4 days ago

ANRO DEADLINE TODAY: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important September 19 Deadline in Securities Class Action - ANRO

Yahoo Finance • 4 days ago

ANRO FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Alto Neuroscience, Inc. (ANRO) of the September 19th Deadline

About

CEO	Dr. Amit Etkin M.D., Ph.D.
CFO	Mr. Nicholas C. Smith
Address	650 Castro Street, Mountain View, CA, United States, 94041
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	76